Health EU CSA proposal successfully submitted!

We have successfully submitted the Health EU CSA proposal! With the ... Read more

Health EU – Human avatars to prevent and cure diseases

Imagine a revolution in personalized healthcare and disease prevention system in Europe, based on human avatars of healthy individuals and patients for the prevention, interception and cure of disease.

Nothing less is the aim of Health EU (healthy you!), an advanced FET Flagship multidisciplinary research initiative in Europe aiming for a paradigm shift to healthcare and for a future sustainable healthcare system.
Stacks Image 3181
A revolution in human model development is now possible with Health EU by leveraging data from omics analyses, medical and imaging data, environmental and life style big data that are continuously updated by a multitude of biosensors at an unprecedented scale. With these complex data sets, first of their kind(s) human avatars will be built that can be personalised and used to prevent and cure each one’s own disease(s). Health EU will exploit most advanced organ-on-chip, smart nanosensor technologies and nanomedicine techniques to realise, validate and use such personalized human avatars in order to create a revolution in healthcare.

Health EU will boost European innovation and create disruptive advances related to big data analytics, smart micro/nano-systems, nanomedicine and new healthcare services and safer and more effective drugs. It will directly contribute to standards for privacy and security of healthcare data, jointly driven by technology and context. Health EU FET Flagship will provide a truly sustainable approach to healthcare and a better Quality of Life to European citizens.

Our Story

The Health EU FET Flagship is a star Flagship initiative born as a result of merging revolutionary ideas about the future of healthcare and leading European research groups from:
  • the past FET Flagship finalist ‘Guardian Angels for a Smarter Life’, and related most advanced edge of the cloud and Internet of Things sensor and smart system integration technology platforms, centered at IMEC, CEA-LETI and Fraunhofer
  • the Organ-on-Chip Flagship initiative led by the Dutch hDMT (Institute for human Organ and Disease Model Technologies) and its European network
  • a large number of groups and leaders formerly being involved in the Flagship Expression of Interest ‘The Future of Health Care: deep data, smart sensors, virtual patients and the Internet-of-Humans
  • the Nanomedicine European Technology platform
  • key partners from the Flag-Era Convergence project
  • many other European universities, research institutes, hospitals, industries and networks that decided to integrate and support Health EU

Partners

The following partners will work together for a year-long coordination action, preparing the final Flagship Initiative.
Stacks Image 3280
Institut Gustave Roussy
France
Alexander M.M. Eggermont
École polytechnique fédérale de Lausanne
Switzerland
Kamiar Aminian, Jürgen Brugger, Giovanni De Micheli, Bart Deplancke, Christian Enz, Mathias Humbert, Adrian Ionescu, Stéphanie Lacour, Matthias Lütolf, Marco Mattavelli, Philippe Renaud, Ali H. Sayed, Anja Skrivervik, Jean-Philippe Thiran, Olivier Verscheure
Universiteit Twente
The Netherlands
Albert van den Berg, Andries van der Meer
Academisch Ziekenhuis Groningen
The Netherlands
Cisca Wijmenga
Academisch Ziekenhuis Leiden
The Netherlands
Christine Mummery
ENEA
Italy
Girolamo Di Francia, Saverio De Vito
Alleanza Contro il Cancro
Italy
Myriam Alkalay
Ares Trading SA
Switzerland
Charles Massin
Bar-Ilan University
Israel
Aharon Gedanken, Jean-Paul Lellouche
Bayer Aktiengesellschaft
Germany
Lars Küpfer
Bluenove
France
Martin Duval, Jerome Brehin
Centre Hospitalier Universitaire de Grenoble
France
Alexandre Moreau-Gaudry
Centre Hospitalier Universitaire Vaudois
Switzerland
Jocelyne Bloch Pasche, Salah D. Qanadli, Piergiorgio Tozzi
Centre National de la Recherche Scientifique CNRS
France
Dominique Collard, Aurélien Bancaud, Vincent Aimez
Centro de Neurociências e Biologia Celular Associacao
Portugal
Lino Ferreira
Charité - Universitätsmedizin Berlin
Germany
Volkmar Falk, Titus Kuehne, Alexander Meyer
CEA
France
Patrick Boisseau, Thomas Ernst
Consiglio Nazionale delle Ricerche
Italy
Luca Businaro, Pietro Siciliano
IU.NET
Italy
Enrico Sangiorgi, Luca Selmi, Daniele Ielmini, Danilo Demarchi, Luca Benini
CSEM
Switzerland
John Farserotu
Danmarks Tekniske Universitet
Denmark
Jan Madsen
E.P.O.S. Iasis Research and Development Ltd
Cyprus
Andreani D. Odysseos, Loizos Economides
Eberhard Karls Universität Tübingen
Germany
Peter Loskill
Edinethics
UK
Donald Bruce
Eidgenössische Technische Hochschule Zürich
Switzerland
Luca Benini, Joachim Buhmann, Stephen Ferguson, Andreas Hierlemann, Christopher Hierold, Walter Karlen, Bradley Nelson, Lothar Thiele
EMPA
Switzerland
Peter Wick
Elektronikas un Datorzinatnu Instituts
Latvia
Modris Greitans, Kaspars Ozols
Fraunhofer Gesellschaft
Germany
Anja Hennemuth, Christine Kallmayer, Peter Ramm, Andreas Schneider, Madalena Cipriano
Institut Català de Nanociència y Nanotecnología
Spain
José Antonio Garrido
Fundación Cidetec
Spain
Iraida Loinaz
Genopole
France
Denis Gauvreau
Goeteborgs Universitet
Sweden
Prof. Jan Borén, MD, Ph.D, Head of the Institute of Medicine
Hellenic Pasteur Institute
Greece
Rebecca Matsas
Hits gGmbH
Germany
Martin Golebiewski, Wolfgang Müller
Hrvatsko katolicko sveuciliste
Croatia
Anto Čartolovni, Hrvoje Meštrić
IBM Research GmbH
Switzerland
Jonas Weiss
Iigm Foundation
Italy
Ruggero de Maria
Imperial College of Science Technology and Medicine
UK
Marisa Miraldo
Infineon Technologies AG
Germany
Knut Hufeld, Reinhard Pufall
Institut Mines-Télecom
France
Marius Preda
Institut national des sciences appliquées de Lyon
France
Eric McAdams
Institut Polytechnique de Grenoble
France
Francis Balestra
Instituto de Salud Carlos III
Spain
Fernando Martin Sanchez
IMT
Romania
Carmen Moldovan, Raluca Muller
Instytut Biocybernetyki i Inżynierii Biomedycznej
Poland
Adam Liebert
Interuniversitair Micro-Electronica Centrum
Belgium
Chris van Hoof
Istituto Superiore Mario Boella
Italy
Paolo Vergori
Karolinska Institutet
Sweden
Anna Herland
Katholieke Universiteit Leuven
Belgium
Georges Gielen
Kungliga Tekniska Högskolan
Sweden
Mikael Ostling, Matthias Uhlen, Ana Rusu
MPI
Germany
Eberhard Bodenschatz, Detlef Lohse, Stuart Parkin
National Center for Scientific Research "Demokritos"
Greece
Athanasios Dimoulas
National Technical University Of Athens - Ntua
Greece
Ioanna Zergioti, Apostolos Klinakis, Dimitris Tsoukalas, Yannis Raptis
NMI
Germany
Udo Kraushaar
Niped Research Foundation
The Netherlands
Coenraad van Kalken
Norges Teknisk-Naturvitenskapelige Universitet Ntnu
Norway
Frank Lindseth
Otto von Guericke Universität Magdeburg
Germany
Steffen Oeltze-Jafra, Hans-Jochen Heinze, Hermann Hinrichs, Oliver Speck, Emrah Düzel
Philips Electronics Nederland B.V.
The Netherlands
Wim Crooijmans
Queen Mary University of London
UK
Anthony Mathur, Sheik Dowlut
RWTH
Germany
Max Lemme
Rijksuniversiteit Groningen
The Netherlands
Reinoud Gosens; Loes Kistemaker
Robert Bosch GmbH
Germany
Franz Lärmer
Roland Berger GmbH
Germany
Steffen Gackstatter
Sabanci Universitesi
Turkey
Gullu Kiziltas Sendur, Gozde Ince
SCIPROM Sàrl
Switzerland
Kirsten Leufgen, Peter Ulrich
SIB Institut Suisse de Bioinformatique
Switzerland
Jerome Dauvillier
SINTEF AS
Norway
Thomas Langø
Slovenskà technickà univerzita v Bratislave
Slovakia
Daniel Donoval
Sorbonne Université
France
Dr Isabella Annesi-Maesano
Stichting Imec Nederland
The Netherlands
Sywert Brongersma
hDMT
The Netherlands
Albert van den Berg, Janny van den Eijnden, Christine Mummery
Stichting Katholieke Universiteit
The Netherlands
Bas Bloem
STMicroelectronics Srl
Italy
Benedetto Vigna, Andrea Di Matteo, Paolo Ferrari, Ernesto Lasalandra
Tallinna Tehnikaulikool
Estonia
Mart Min
Technische Universität Graz
Austria
Torsten Mayr
Technische Universität München
Germany
Sandra Hirche, Daniel Cremers, Nassir Navab, Bjoern Menze
Technische Universität Wien
Austria
Clemens Heitzinger, Peter Ertl, Mario Rothbauer
Technische Universität Berlin
Germany
Roland Lauster
Technische Universiteit Delft
The Netherlands
Pasqualina M. Sarro, Wouter Serdijn
Technische Universiteit Eindhoven
The Netherlands
Jaap den Toonder, Prof
Teknologian Tutkimuskeskus Vtt Oy
Finland
Ari Alastalo, Veikko Ikonen, Eija Kaasinen
Tel Aviv University
Israel
Dan Peer
University of Cambridge
United Kingdom
Daniel Popa, Flurin Udrea
The University of Auckland
New Zealand
Peter Hunter, Pau Medrano-Gracia, David Nickerson
TTY-säätiö
Finland
Mari Pekkanen-Mattila
Universidad de Zaragoza
Spain
Ignacio Ochoa, Manuel Doblaré; Luis Fernandez
Universita Campus Bio Medico di Roma
Italy
Marco Santonico, Giorgio Pennazza
Universita degli Studi di Cagliari
Italy
Luigi Raffo
Universita degli Studi di Roma Torvergata
Italy
Eugenio Martinelli; Arianna Mencattini
Università degli Studi di Milano-Bicocca
Italy
Marco Antoniotti
Universität Bern
Switzerland
Stephen Leib, Alban Ramette, Denis Grandgirard, Thomas Geiser, Olivier Guenat
Universitaet Leipzig
Germany
Thomas Neumuth
Universitaetsklinikum Aachen
Germany
Fabian Kiessling
Universitat des Saarlandes
Germany
Frank Lammert, Norbert Graf
Universitat Zurich
Switzerland
Giacomo Indiveri
Universitatea Politehnica Din Bucuresti
Romania
Gheorghe Brezeanu, Gheorghe Militaru, George Stanciu
Universitätsklinikum Jena
Germany
Alexander Mosig
Université Catholique de Louvain
Belgium
Denis Fladre, Jean-Pierre Raskin
Université de Lausanne
Switzerland
Ioannis Xenarios
Université du Luxembourg
Luxemburg
Jens Schwamborn, Paul Wilmes
Université Lyon 1 Claude Bernard
France
Abdelhamid Errachid El Salhi, Michel Ovize
Universite Paris-Sud
France
Patrick Couvreur, Elie Lefeuvre
Universiteit Maastricht
The Netherlands
Prof. dr. Pamela Habibović
Universitetet i Oslo
Norway
Stefan Krauss
University College Cork - National University of Ireland
Ireland
Paul Galvin, David Wilson
University of Brighton
United Kingdom
Matteo Santin
University of Surrey
United Kingdom
Christian Heiss, Helen Griffiths, A. Gawer
Uppsala Universitet
Sweden
Susan Peacock
VRVis
Austria
Katja Bühler
Weizmann Institute of Science
Israel
Eran Segal
Over 100 partners from more than 20 EU countries already confirmed their interest in participating in the final Health EU Flagship Initiative.
The Health EU Stakeholder Forum will play a crucial role in shaping our Flagship vision and its implementation by considering the interactive involvement of big industries, SMEs, startups, patient organizations, regulatory bodies, etc.

The Chairs of the Health-EU Stakeholder Forum are Prof. Christofer Hierold (ETHZ) and Dr. Franz Lärmer (VP Corporate Research and Advanced Engineering - Robert Bosch GmbH, Germany).
Stacks Image 3278
Name of the organisationPerson of contactCountry
3D PLUS SASPascal CoudercFrance
AbbVieThomas JahnGermany
AlfaBetaNetLucio AnnunziatoItaly
AlveoliX AGOlivier Guenat, Nina Hobi, Janick StuckiSwitzerland
AMOMax LemmeGermany
Axe PIAxel Gerhardt
BarmerChristoph StraubGermany
Bayer AGLars KüpferGermany
Bioanalytic MünsterKlaus-Michael WeltringGermany
Biocam Scarl Lucio AnnunziatoItaly
BiovistaAndreas Persidis, Eftychia LekkaGreece
Bosch BKKFranz LaermerGermany
Bracco Imaging s.p.a.Fulvio UggeriItaly
CEDEO SASLeonardo Chiariglione Italy
Centre for Process InnovationCharanjeet SinghUnited Kingdom
CIFARAlan BernsteinCanada
Copenhagen Center for Health Technology (cachet) Jakob E. Bardram, Professor and DirectorDenmark
Corti Michael R. Boesen, PhD, Co-founder and VP Special ProjectsDenmark
CPH Health CHCHenning LangbergDenmark
Cyprus Chamber of Commerce and IndustryLeonidas PaschalidesCyprus
Cyprus Ministry of HealthChristina YiannakiCyprus
DDS DiagnosticDana StanRomania
Diavita LtdDimiter DimitrovBulgaria
Dr. SchärOmbretta PolenghiItaly
Dutch Heart FoundationRebecca Abma-SchoutenThe Netherlands
Edinethics LtdDonald BruceUnited Kingdom
EGANCees Smit, Cor OosterwijkThe Netherlands
EIT-HealthJan-Philipp BeckGermany
Eriksholm Research Center (part of Oticon)Uwe Hermann, DirectorDenmark
European Federation of Neurological Associations (EFNA)Cathalijne van DoorneBelgium
European Federation of Pharmaceutical Industries and Associations (EFPIA)Magda ChlebusBelgium
European Lung Foundation (ELF)Emma Thompson, Isabel SairavaUnited Kingdom
European Society for Biomaterials ESBPamela HabibovicFrance
F.R.S.-FNRS Fonds de la Recherche ScientifiqueVéronique HalloinBelgium
Fonds de recherche du QuébecRémi QuirionCanada
Genomics CanadaMarc LepageCanada
GenomSys SAClaudio AlbertiSwitzerland
GlaxoSmithKlineAnthony BahinskiUSA
greenTEG AGWulf GlatzSwitzerland
Génome QuébecDaniel CoderreCanada
Hauptverband der österreichischen SozialversicherungsträgerAlexander BiachAustria
Health Insurance OrganisationAthos TsinontidesCyprus
Helmholtz Inst for Pharma scienceClaus-Michael LehrGermany
InnovAALPietro SicilianoItaly
INRA - Human Nutrition UnitSergio Polakof, Estelle Pujos-Guillot France
InSphero AGOlivier Frey, Jan LichtenbergSwitzerland
Institute for Clinical Pharmacology (IKP)Matthias SchwabGermany
Intelligent Voice LtdFranceGérard Chollet
IST AGMirko LehmannSwitzerland
Istituto Superiore di SanitàGiovanna SchiavoniItaly
JanssenRachel AdamsUnited Kingdom
liferesult srlMassimo PistoiaItaly
LioniX International BVHenk LeeuwisThe Netherlands
LundbeckKenneth ThistrupDenmark
MaxWell BiosystemsUrs Frey, Michele FiscellaSwitzerland
Medicines Evaluation Board (the Netherlands)Jan Willem van der LaanThe Netherlands
MedTronicIves BayonFrance
Melanoma Patient Network EuropeBettina RyllBelgium
Merck KGaA (Ares Trading SA)Charles MassinSwitzerland
MicronitRonny van 't OeverThe Netherlands
Microsoft DenmarkKim IbfeltDenmark
Mila - Quebec Articifcial Intelligence InstituteValérie PisaneCanada
Military Hospital BrusselsVanhoutteBelgium
MinacNedRonny van ‘t OeverThe Netherlands
Mobile Health UnitValerie StormsBelgium
NanobiotixAgnes PottierFrance
National Research Council CanadaJean-François HouleCanada
NC3RsSam JacksonUnited Kingdom
Neurescue Habib Frost, Founder and CEODenmark
Nordic.AILisa MallnerDenmark
NovartisKlaus SeuwenSwitzerland
NXP SemiconductorsRadu SurdeanuThe Netherlands
Ontario GenomicsBettina HamelinCanada
PfizerMark Soued The Netherlands
Philips Electronics Nedeland B.V.Sieger SwavingThe Netherlands
Photonics 21Jürgen Popp, Thomas MayerhoeferGermany
Polytechnique MontréalFrançois BertrandCanada
Praxis PharmaceuticalEusebio GainzaSpain
Praxis Pharmaceutical (Keralty)Eusebio GainzaLatin America
Pryv SA Hubert RidolphiSwitzerland
Robert Bosch GmbHJürgen GrossGermany
Roland Berger GmbHSteffen GackstatterGermany
S.C. Telemedica S.R LMioara RaduRomania
SanofiHartmut RuettenGermany
ServierOlivier NosjeanFrance
SoitecIonut Radu France
ST MicroelectronicsG. Desoli, Rolandi Canegallo, A. Cremonesi, Sabina ConociItaly
Syndicat National de l’Industrie des Technologies Médicales (SNITEM)Florent SurugueFrance
Texas InstrumentsGiovanni FrattiniUnited States
Tissue Click LtdGary Phillips, Anna GuildfordUnited Kingdom
Université de SherbrookeVincent AimezCanada
Vector Institute for Artificial IntelligenceGarth GibsonCanada
VITOBart Van MeerbergenBelgium
Wageningen - Food & Biobased ResearchJurriaan Mes, Liesbeth Luijendijk, Jan Top, Harry WichersThe Netherlands
Wyss Center for Bio and NeuroengineeringTracy LaabsSwitzerland
XsensioEsmeralda MegallySwitzerland
Zilveren Kruis AchmeaAnja MoonenThe Netherlands

News and Events

Health EU CSA proposal successfully submitted!

We have successfully submitted the Health EU CSA proposal!
  • With the ambitious unifying goal of empowering every citizen with a Human Avatar enabling access to comprehensive personalized healthcare, healthy lifestyle and disease prevention.
  • With a Consortium of 110 partners from 27 European countries, Canada and New Zealand, more than 75 stakeholders and hundreds of enthusiastic supporters across Europe.
  • With an International Advisory Board including 2 Nobel Laureates, several ex-Ministers of Health of EU countries and many international leaders and experts in Europe, USA, and Canada.
Many thanks to all the Consortium contributors, to the Strategic Board members and to Workpackage and Task Leaders, for their hard work and the outstanding product!

We are ready for the next step!

The Coordinators,
  • Alexander M.M. Eggermont, MD, PhD, Directeur Général Gustave Roussy, Professeur Oncologie, Université Paris-Sud, France
  • Adrian M. Ionescu, PhD, Director Nanolab-EPFL, Professor of Nanoelectronics, Ecole Polytechnique Fédérale de Lausanne, Switzerland
  • Albert Van den Berg, PhD, Director MESA+, Professor of Biomedical Nanotechnology, University of Twente, the Netherlands


Presentation at CEO Summit 2018

Patrick Boisseau, Deputy Head of Division, European Affairs at CEA-LETI and member of the Health EU steering board, presented the Health EU Flagship approach today at the CEO Summit 2018 in Brussels. The audience composed of 60+ industrial leaders in medtech and diagnostics companies was delighted about this foresight looking lecture. Some interesting questions about ethical and societal issues related to avatars or “when will it be available” gave rise for discussion and some very positive feedback was received during the coffee breaks.

Health EU at ETPN 2018, Berlin

Patrick Boisseau, Deputy Head of Division, European Affairs at CEA-LETI and Chairman of the ETPN, presented Health EU Flagship approach at ETPN 2018, Berlin, Germany, in a talk entitled: ''Human avatars to prevent and cure diseases Health EU vision for a sustainable future of the European healthcare'', attracting significant support and high interest from the audience for the Health EU Flagship.

Two EPFL projects make it to the second round

Both of the EPFL projects that applied for the European Commission’s FET Flagship programme have successfully cleared the first hurdle. These projects are the Time Machine, headed by Frédéric Kaplan at the Digital Humanities Laboratory, and Health EU, run by Adrian Ionescu at the Nanoelectronic Devices Laboratory (Nanolab). If selected, they will receive one billion euros over ten years as part of the European Commission’s ambitious funding programme.

With Health EU, everyone will one day have their own medical avatar – a virtual replica of themselves featuring their own personal data – that could improve the way their health is managed and the treatments they are given. This international project, led by a consortium headed by EPFL and the University of Twente, aims to achieve enhanced disease prevention, early diagnosis, more accurate monitoring and customized, targeted administration of medicines and treatments, especially for increasingly common diseases such as cancer and cardiovascular, chronic and neurodegenerative disorders.

The Time Machine is based on the Venice Time Machine (VTM), a project that started in 2012 and served as a proof of concept. The VTM aimed to build a multidimensional model of the city that spans the past millennium, using millions of historical documents stored in a variety of formats. After five years, the project team has scanned 190,000 records from the Venice State Archive along with 720,000 photographs and 3,000 books on Venice’s history. The objective of the Time Machine is to replicate the VTM across Europe. It will create a large-scale simulator for mapping 2,000 years of European history and turning the huge archives and sizeable museum collections into one big digital information system.

A total of 33 projects from universities across Europe have applied for the programme, which is intended to support future and emerging technologies (FET). Only 17 of them – just over half – were selected for the second round, scheduled to end on 18 September 2018.EPFL also plays a key role in a third project in the running for a FET Flagship, Robotics Flagship, which made it through to the second round as well.

The full EPFL press release including more information about the proposals you can find here.

Outstanding support for Health EU

Professor Ben Feringa, who won the 2016 Nobel Prize in chemistry for the development of molecular machines, expresses his appreciation of the Health EU proposal: “This is a very ambitious programme that combines modern science and technology to create new opportunities for the future of healthcare and keep it affordable.”

Professor Feringa is a pioneer in the field of molecular engines, catalysis and smart medication.

Health EU proposal invited for next stage of competition!

Excellent news: The European Commission has invited the Health EU proposal to enter the next stage of competition for the selection of new EU Flagships for Future and Emerging Technologies.

We are thrilled to be one step closer to the realisation of our dream: a revolution in personalized healthcare and disease prevention system in Europe, based on human avatars of healthy individuals and patients for the prevention, interception and cure of disease.

Health EU press release launched by EPFL

The Health EU coordinating organisation, Ecole polytechnique fédérale de Lausanne (EPFL) has published today a press release presenting the project. Enjoy reading!

Health EU phase 1 proposal submitted!

The Health EU phase 1 proposal has been submitted successfully yesterday!

It is one of 33 proposals submitted to the topic FETFLAG-01-2018: Preparatory Actions for new FET Flagships.

The results for phase 1 of the evaluation should be known in 3 months from now.

Website published!

The Health EU website is online! Further information and updates will follow after the Christmas Break. Happy holidays!

© Health EU project - created by SCIPROM

Privacy policy